(Q41460254)

1 October 2017

1 reference

title

Migraine prophylactic drugs: proof of efficacy, utilization and cost (English)

1 reference

1 October 2017

N M Ramadan

1

1 reference

1 October 2017

L L Schultz

series ordinal

2

1 reference

1 October 2017

S J Gilkey

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

17

1 reference

1 October 2017

73-80

1 reference

1 October 2017

2

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

1 October 2017

1 reference

The treatment of migraine with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Propranolol in the Treatment of Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Migraine prophylaxis. A comparison of propranolol and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Classic migraine: effective prophylaxis with metoprolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

A Double Blind Trial of Acebutolol For Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Alprenolol for migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Atenolol in migraine prophylaxis a double-blind cross-over multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Amitriptyline in Migraine Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Fluoxetine prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Successful migraine prophylaxis with naproxen sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Aspirin prophylaxis in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Low-dose aspirin for migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Fenoprofen in the prophylaxis of migraine: a double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Effect of prophylactic administration of nimodipine in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

A Placebo-Controlled, Double-Blind, Cross-Over Trial of Flunarizine in Common Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Flunarizine in migraine prophylaxis: an Indian trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Cerebrospinal fluid gamma aminobutyric acid levels in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Methysergide in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Pizotifen (BC 105) in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Double blind study of clonidine and placebo for the prophylactic treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

Meta-analysis of Randomized Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1997.1702073.X

10.1046/J.1468-2982.1997.1702073.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference